Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial.

Saved in:
Bibliographic Details
Title: Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial.
Authors: Durovni, Betina1 (AUTHOR), Cordeiro-Santos, Marcelo2,3,4 (AUTHOR), Cavalcante, Solange Cesar1 (AUTHOR), Spener-Gomes, Renata2,3,5 (AUTHOR), Garcia, Jamile1 (AUTHOR), Cohn, Silvia6 (AUTHOR), Saraceni, Valeria1 (AUTHOR), Kohler, Beatriz6 (AUTHOR), Moulton, Lawrence H.6,7 (AUTHOR), Brito da Souza, Alexandra2 (AUTHOR), Berihun, Abiye6,7 (AUTHOR), Marzinke, Mark8,9 (AUTHOR), Chaisson, Richard E.6,7 (AUTHOR) rchaiss@jhmi.edu
Source: PLoS Medicine. 2/10/2026, Vol. 23 Issue 2, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15491277
DOI:10.1371/journal.pmed.1004758